Literature DB >> 1824905

Influenza A virus in vitro transcription: roles of NS1 and NP proteins in regulating RNA synthesis.

R Skorko1, D F Summers, J M Galarza.   

Abstract

To study the mechanisms by which the influenza A virus RNA-dependent RNA polymerase switches from transcription to replication we have devised a riboprobe protection technique with which we analyzed the 3' end sequence of (+)-strand RNA products of an in vitro transcription reaction containing purified virion-RNP complexes in the presence and the absence of the putative regulatory proteins NP and NS1. We found that the addition of these proteins did not result in the synthesis of full-length (+)-strand RNA products resulting from read-through of the polyadenylation signal or replication. Because NS1 and NP are both phosphoproteins we searched for protein kinase activity that might play a role in regulating RNA synthesis. We showed that virion RNP complexes phosphorylated NS1 but possessed no autophosphorylating activity. Soluble NP protein derived from RNP complexes did not phosphorylate NS1, but did phosphorylate casein. When NP protein was dephosphorylated, however, it no longer phosphorylated casein. We also showed that NS1 was an ssRNA-binding protein which binds nonspecifically to all ssRNA, and that this activity is not dependent on its state of phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1824905     DOI: 10.1016/0042-6822(91)90080-u

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Definition of the minimal viral components required for the initiation of unprimed RNA synthesis by influenza virus RNA polymerase.

Authors:  M T Michael Lee; Konrad Bishop; Liz Medcalf; Debra Elton; Paul Digard; Laurence Tiley
Journal:  Nucleic Acids Res       Date:  2002-01-15       Impact factor: 16.971

2.  Effective inhibition of influenza virus production in cultured cells by external guide sequences and ribonuclease P.

Authors:  D Plehn-Dujowich; S Altman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

3.  Regulation of influenza virus RNA polymerase activity by cellular and viral factors.

Authors:  K Shimizu; H Handa; S Nakada; K Nagata
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

4.  Interaction cloning of NS1-I, a human protein that binds to the nonstructural NS1 proteins of influenza A and B viruses.

Authors:  T Wolff; R E O'Neill; P Palese
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  Temperature-sensitive lesions in two influenza A viruses defective for replicative transcription disrupt RNA binding by the nucleoprotein.

Authors:  L Medcalf; E Poole; D Elton; P Digard
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

6.  Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells.

Authors:  E Hatada; S Saito; R Fukuda
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

7.  Expression and characterisation of the influenza A virus non-structural protein NS1 in yeast.

Authors:  A C Ward; A A Azad; I G Macreadie
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design.

Authors:  Andy Ka-Leung Ng; Hongmin Zhang; Kemin Tan; Zongli Li; Jin-huan Liu; Paul Kay-Sheung Chan; Sui-Mui Li; Wood-Yee Chan; Shannon Wing-Ngor Au; Andrzej Joachimiak; Thomas Walz; Jia-Huai Wang; Pang-Chui Shaw
Journal:  FASEB J       Date:  2008-07-09       Impact factor: 5.191

Review 9.  New aspects of influenza viruses.

Authors:  M W Shaw; N H Arden; H F Maassab
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

10.  Influenza virion-derived viral ribonucleoproteins synthesize both mRNA and cRNA in vitro.

Authors:  F T Vreede; G G Brownlee
Journal:  J Virol       Date:  2006-12-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.